title: Do we need a replacement medication for influenza with good efficacy?
authors.affiliation: Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences, Tehran, Iran. mahmoudarastoo@hotmail.co.uk.
authors.forename: Mahmoud
authors.initials: M
authors.lastname: Arastoo
authors.affiliation: Genetic Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran. hrkhkh@yahoo.com.
authors.forename: Hamid Reza Khorram
authors.initials: HR
authors.lastname: Khorshid
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D004357:Drug Synergism; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects* / Q000472:pathogenicity; D007251:Influenza, Human / Q000175:diagnosis / Q000188:drug therapy* / Q000821:virology; D053139:Oseltamivir / Q000009:adverse effects / Q000627:therapeutic use*; D010936:Plant Extracts / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D053243:Zanamivir / Q000009:adverse effects / Q000627:therapeutic use*; D013440:Sulfides
chemical_list: D000998:Antiviral Agents; D004338:Drug Combinations; D007211:Indoles; D053139:Oseltamivir; D010936:Plant Extracts; D053243:Zanamivir; C555145:setarud; C086979:umifenovir; D013440:Sulfides